Vcanbio Cell & Gene Engineering Corp., Ltd 600645.SS Stock
Vcanbio Cell & Gene Engineering Corp., Ltd Price Chart
Vcanbio Cell & Gene Engineering Corp., Ltd 600645.SS Financial and Trading Overview
Contents
- Vcanbio Cell & Gene Engineering Corp., Ltd Price Chart
- Vcanbio Cell & Gene Engineering Corp., Ltd 600645.SS Financial and Trading Overview
- Valuation Measures
- Trading Information
- Financial Highlights
- Profile of Vcanbio Cell & Gene Engineering Corp., Ltd
- Q&A For Vcanbio Cell & Gene Engineering Corp., Ltd Stock
| Vcanbio Cell & Gene Engineering Corp., Ltd stock price | 15.77 CNY |
| Previous Close | 16.99 CNY |
| Open | 16.99 CNY |
| Bid | 16.96 CNY x 0 |
| Ask | 16.97 CNY x 0 |
| Day's Range | 16.88 - 17.02 CNY |
| 52 Week Range | 15.58 - 20.55 CNY |
| Volume | 2.72M CNY |
| Avg. Volume | 6.26M CNY |
| Market Cap | 7.94B CNY |
| Beta (5Y Monthly) | 0.386301 |
| PE Ratio (TTM) | 70.666664 |
| EPS (TTM) | 0.28 CNY |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | August 10, 2001 |
| 1y Target Est | N/A |
600645.SS Valuation Measures
| Enterprise Value | 6.69B CNY |
| Trailing P/E | 70.666664 |
| Forward P/E | 38.545452 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 5.158681 |
| Price/Book (mrq) | 2.2187335 |
| Enterprise Value/Revenue | 4.346 |
| Enterprise Value/EBITDA | 27.788 |
Trading Information
Vcanbio Cell & Gene Engineering Corp., Ltd Stock Price History
| Beta (5Y Monthly) | 0.386301 |
| 52-Week Change | -12.64% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 20.55 CNY |
| 52 Week Low | 15.58 CNY |
| 50-Day Moving Average | 17.79 CNY |
| 200-Day Moving Average | 17.98 CNY |
600645.SS Share Statistics
| Avg. Volume (3 month) | 6.26M CNY |
| Avg. Daily Volume (10-Days) | 3.3M CNY |
| Shares Outstanding | 467.95M |
| Float | 327.74M |
| Short Ratio | N/A |
| % Held by Insiders | 26.80% |
| % Held by Institutions | 5.87% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 16.983:10 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 7.44% |
| Operating Margin (ttm) | 8.89% |
| Gross Margin | 67.50% |
| EBITDA Margin | 15.64% |
Management Effectiveness
| Return on Assets (ttm) | 1.66% |
| Return on Equity (ttm) | 2.94% |
Income Statement
| Revenue (ttm) | 1.54B CNY |
| Revenue Per Share (ttm) | 3.24 CNY |
| Quarterly Revenue Growth (yoy) | -4.20% |
| Gross Profit (ttm) | N/A |
| EBITDA | 240.62M CNY |
| Net Income Avi to Common (ttm) | 114.54M CNY |
| Diluted EPS (ttm) | 0.24 |
| Quarterly Earnings Growth (yoy) | 4.29% |
Balance Sheet
| Total Cash (mrq) | 1.38B CNY |
| Total Cash Per Share (mrq) | 2.95 CNY |
| Total Debt (mrq) | 140.29M CNY |
| Total Debt/Equity (mrq) | 3.82 CNY |
| Current Ratio (mrq) | 1.626 |
| Book Value Per Share (mrq) | 7.644 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 258.86M CNY |
| Levered Free Cash Flow (ttm) | 130.41M CNY |
Profile of Vcanbio Cell & Gene Engineering Corp., Ltd
| Country | China |
| State | N/A |
| City | Tianjin |
| Address | Huayuan Industrial Zone |
| ZIP | 300384 |
| Phone | 86 22 5877 5766 |
| Website | https://www.vcanbio.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 2332 |
Vcanbio Cell & Gene Engineering Corp., Ltd, together with its subsidiaries, primarily engages in the preparation and storage of cell tests in the People's Republic of China. The company provides cell test preparation and storage services for umbilical cord blood hematopoietic stem cells, umbilical cord mesenchymal stem cells, placental sub totipotent stem cells, immune cells, adipose stem cells, and dental stem cells. It also provides genetic testing services related to non-invasive prenatal genetic testing during pregnancy, safe medication guide gene testing for children and adults, disease genetic testing, disease susceptibility gene testing, etc.; and in vitro diagnostic raw materials, such as monoclonal antibodies and polyclonal antibody products. In addition, the company is involved in the research, development, production, and sales of biological genes, proteins, antibodies, pharmaceutical intermediates, and experimental synthetic agents; and in vitro diagnostic reagents and medical devices. Vcanbio Cell & Gene Engineering Corp., Ltd was founded in 1992 and is based in Tianjin, the People's Republic of China.
Q&A For Vcanbio Cell & Gene Engineering Corp., Ltd Stock
What is a current 600645.SS stock price?
Vcanbio Cell & Gene Engineering Corp., Ltd 600645.SS stock price today per share is 15.77 CNY.
How to purchase Vcanbio Cell & Gene Engineering Corp., Ltd stock?
You can buy 600645.SS shares on the Shanghai exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Vcanbio Cell & Gene Engineering Corp., Ltd?
The stock symbol or ticker of Vcanbio Cell & Gene Engineering Corp., Ltd is 600645.SS.
Which industry does the Vcanbio Cell & Gene Engineering Corp., Ltd company belong to?
The Vcanbio Cell & Gene Engineering Corp., Ltd industry is Biotechnology.
How many shares does Vcanbio Cell & Gene Engineering Corp., Ltd have in circulation?
The max supply of Vcanbio Cell & Gene Engineering Corp., Ltd shares is 467.95M.
What is Vcanbio Cell & Gene Engineering Corp., Ltd Price to Earnings Ratio (PE Ratio)?
Vcanbio Cell & Gene Engineering Corp., Ltd PE Ratio is 56.32143000 now.
What was Vcanbio Cell & Gene Engineering Corp., Ltd earnings per share over the trailing 12 months (TTM)?
Vcanbio Cell & Gene Engineering Corp., Ltd EPS is 0.28 CNY over the trailing 12 months.
Which sector does the Vcanbio Cell & Gene Engineering Corp., Ltd company belong to?
The Vcanbio Cell & Gene Engineering Corp., Ltd sector is Healthcare.